MiR-26b inhibits melanoma cell proliferation and enhances apoptosis by suppressing TRAF5-mediated MAPK activation

• Published in: Biochemical and biophysical research communications 2016-03, Vol.471 (3), p.361-367
• Main Authors: Li, Meng, Long, Chaoqin, Yang, Guilan, Luo, Yang, Du, Hua
• Format: Article
• Language: English
• Subjects: 60 APPLIED LIFE SCIENCES; APOPTOSIS; Apoptosis - genetics; Cell Line, Tumor; CELL PROLIFERATION; cell viability; COLONY FORMATION; dephosphorylation; Down-Regulation - genetics; Enzyme Activation; FLUORESCEIN; gene overexpression; GENES; Humans; ISOTHIOCYANATES; LUCIFERASE; MAP Kinase Signaling System - genetics; Melanoma; Melanoma - metabolism; Melanoma - pathology; MELANOMAS; MicroRNAs - metabolism; miR-26b; mitogen-activated protein kinase; Mitogen-Activated Protein Kinase Kinases - metabolism; PLASMIDS; POLYMERASE CHAIN REACTION; Proliferation; quantitative polymerase chain reaction; reporter genes; signal transduction; TNF Receptor-Associated Factor 5 - metabolism; TRAF5; TRANSMISSION ELECTRON MICROSCOPY
• ISSN: 0006-291X; 1090-2104
• DOI: 10.1016/j.bbrc.2016.02.021

Alterations in microRNA-26b (miR-26b) expression have been shown to participate in various malignant tumor developments. However, the possible function of miR-26b in human melanoma cells remains unclarified. In this study, quantitative polymerase chain reaction was used to explore the expression profiles of miR-26b in melanoma cells. The effect of miR-26b on cell viability was determined by using MTT assays and colony formation assay. The apoptosis levels were evaluated by using Annexin V/fluorescein isothiocyanate (FITC) apoptosis detection kit and the apoptosis cells were confirmed by Transmission Electron Microscopy (TEM). Luciferase reporter plasmids were constructed to confirm direct targeting. Our study found that the expression of miR-26b was downregulated in human melanoma specimens. Overexpression of miR-26b significantly increased the anti-proliferative effects and apoptosis in A375 and B16F10 melanoma cells. In addition, luciferase gene reporter assays confirmed that TRAF5 was a direct target gene of miR-26b and the anti-tumor effect of miR-26b in melanoma cells was significantly counteracted by treatment with TRAF5 overexpression. Furthermore, the molecular mechanisms underlying the tumor suppressor of miR-26b in malignant melanomas may be due to the dephosphorylation of MAPK pathway caused by the decrease in TRAF5 expression when miR-26b is up-regulated in melanoma cells. These findings indicate that miR-26b might influence TRAF5-MAPK signaling pathways to facilitate the malignant progression of melanoma cells. •miR-26b is downregulated in human melanomas.•miR-26b suppressed melanoma cell proliferation and enhanced cell apoptosis.•TRAF5 is a direct target of miR-26b and inversely correlates with miR-26b expression.•miR-26b modulated MAPK signaling pathway by targeting TRAF5.